Fig. 5
Comparison of OS in ESCC patients aged ≤ 60 years (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)
Fig. 5 | World Journal of Surgical Oncology
Comparison of OS in ESCC patients aged ≤ 60 years (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)